Drug class
Topical Immunomodulator - Imidazoquinolinamines
Topical immunomodulators of the imidazoquinolinamine class, prototyped by imiquimod, are synthetic small-molecule immune response modifiers applied dermally to stimulate localized cell-mediated immunity. Read more about Topical Immunomodulator - Imidazoquinolinamines
16 drugs in this class 8 manufacturers
Drugs in Topical Immunomodulator - Imidazoquinolinamines
IMIQUIMOD
KERIDA (imiquimod/tretinoin/salicylic acid)
KYNARA (imiquimod/levocetirizine dihydrochloride/niacinamide)
IMIQUIMOD
IMIQUIMOD
Topical immunomodulators of the imidazoquinolinamine class, prototyped by imiquimod, are synthetic small-molecule immune response modifiers applied dermally to stimulate localized cell-mediated immunity.
They act primarily as Toll-like receptor 7 agonists, triggering dendritic cells and macrophages to produce interferon-alpha and other proinflammatory cytokines that induce apoptosis of diseased cells and clear lesions.
Clinically, these agents are utilized in dermatologic conditions, including external genital and perianal warts caused by human papillomavirus, actinic keratosis, and superficial basal cell carcinoma.
-
nih.gov
Topical immunomodulators of the imidazoquinolinamine class, prototyped by imiquimod, are synthetic small-molecule immune response modifiers applied dermally to stimulate localized cell-mediated immunity
-
nih.gov
Topical immunomodulators of the imidazoquinolinamine class, prototyped by imiquimod, are synthetic small-molecule immune response modifiers applied dermally to stimulate localized cell-mediated immunity They act primarily as Toll-like receptor 7 agonists, triggering dendritic cells and macrophages to produce interferon-alpha and other proinflammatory cytokines that induce apoptosis of diseased cells and clear lesions
-
drugbank.com
They act primarily as Toll-like receptor 7 agonists, triggering dendritic cells and macrophages to produce interferon-alpha and other proinflammatory cytokines that induce apoptosis of diseased cells and clear lesions
-
nih.gov
Clinically, these agents are utilized in dermatologic conditions, including external genital and perianal warts caused by human papillomavirus, actinic keratosis, and superficial basal cell carcinoma
-
nih.gov
Clinically, these agents are utilized in dermatologic conditions, including external genital and perianal warts caused by human papillomavirus, actinic keratosis, and superficial basal cell carcinoma
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.